Transarterial Chemoembolization for Primary Hepatocellular Carcinoma in Patients at High Risk

TACE in patients considered at high risk does not necessarily incur a higher incidence of morbidity or mortality. Patient selection should be based on extent of disease, and these tumors should be treated selectively at a segmental level if possible.